the impact of gene mutations on prognosis in cll
Published 2 years ago • 694 plays • Length 2:34Download video MP4
Download video MP3
Similar videos
-
2:12
the impact of genetic abnormalities on treatment decisions in cll
-
4:31
the impact of high and low burden tp53 mutations on risk and treatment decision in cll
-
0:53
clinical significance of ig gene mutations in cll
-
2:27
understanding how genetic mutations affect outcome in cll
-
1:07
testing for ighv and tp53 mutations to guide treatment decisions in cll
-
2:02
important prognostic factors to evaluate in cll patients in the era of small molecules
-
2:02
the prognostic impact of tp53 and ighv status in the era of targeted therapies in cll
-
3:10
impact of splicing factor mutations on aml treatment
-
9:48
notch signaling
-
3:08
recent updates on tp53 mutation in cll
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
1:04
defining high-risk cll: known and emerging mutations
-
1:50
the impact of ighv mutational status in treatment decisions in cll
-
0:46
the prognostic impact of tp53 mutation in mpns
-
1:42
the importance of genomic testing in cll prognosis
-
2:13
cll at a genomic level
-
2:05
the role of notch1 mutation in cll
-
1:36
the importance of genomic testing when making treatment decisions in cll
-
1:44
ibrutinib and fcr in cll irrespective of ighv mutation status
-
2:10
ngs: changes in cll management
-
3:55
the origins of mutated and unmutated cll